こころの健康科学研究事業中間・事後評価委員名簿 ＜精神疾患分野＞
（○：委員長）
○
| 樋口 輝彦 | 国立精神・神経センター 総長 |
| 気分障害の薬理・生化学、臨床精神薬理、うつ病の臨床研究 | |
| Motohashi N, Shioe K, Nakamura J, Ohshima A, Ymada K, Ozawa H, Someya T, Uchitomi Y, Higuchi T:Revised psychopharmacological algorithms for the treatment of mood disorders in Japan. Int'l J Psychiatry in Clinical Practice. 12 (1);11-18, 2008. | |
| Nakatani N, Ohnishi T, Iwamoto K, Watanabe A, Iwayama Y, Yamashita S, Ishitsuka Y, Moriyama K, Nakajima M, Tatebayashi Y, Akiyama H, Higuchi T, Kato T, Yoshikawa T: Expression analysis of actin-related genes as an underlying mechanism for mood disorders. Biochem Biophys Res Commun. 352(3):780-786. 2007 | |
| Kunugi H, Ida I, Owashi T, Kimura M, Inoue Y, Nakagawa S, Yabana T, Urushibara T, Kanai R, Aihara M, Yuuki N, Otsubo T, Oshima A, Kudo K, Inoue T, Kitaichi Y, Shirakawa O, Isogawa K, Nagayama H, Kamijima K, Nanko S, Kanba S, Higuchi T, Mikuni M: Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study. Neuropsychopharmacology 31(1): 212-220, 2006. | |
| 太田 龍朗 | 名古屋大学名誉教授、北林病院名誉院長 |
| 精神医学・精神生理学・睡眠学 | |
| 睡眠のリズム障害からみた現代社会. 太田龍朗 綜合臨床58(3);436-442 2009 | |
| 「専門医のための精神科臨床リュミエール 8. 精神疾患における睡眠障害の対応と治療」 太田龍朗編集企画, 内山真責任編集, 中山書店,（2009） | |
| 「専門医のための精神科臨床リュミエール 18. 職場復帰のノウハウとスキル」太田龍朗編集企画, 中村 純責任編集, 中山書店,（2009） | |
| 鹿島 晴雄 | 慶應義塾大学医学部精神神経科学教室 教授 |
| 精神医学 精神病理学 神経心理学 | |
| Novel rating scales for schizophrenia - Targeted Inventory on Problems in Schizophrenia(TIP-Ss) and Functional Assessment for Comprehensive Treatment of Schizophrenia(FACT-Ss). Takefumi Suzuki, Hiroyuki Uchida, Kensuke Nomura, Hiroyoshi Takeuchi,Shinichiro Nakajima, Akira Tanabe, Gohei Yagi, Koichiro Watanabe, Haruo Kashima: Schizophrenia Research, 106(2-3):328-336,2008. |
|
| Changes in regional blood flow during acute electroconvulsive therapy in patients with depression: Positron emission tomographic study. Harumasa Takano, Nobutaka Motohashi, T.Uema, K.Ogawa, T.Ohnishi, M.Nishikawa, Haruo Kashima, H.Matsuda: British Journal of Psychiatry, 190:63-68,2007. |
|
| 失語症セラピーと認知リハビリテーション． 鹿島晴雄他共編著, 永井書店,（2008） |
|
| 加藤 進昌 | 昭和大学医学部精神医学教室教授 昭和大学附属烏山病院院長 |
| 精神医学 | |
| N Kato, M Kawata, R.K.Pitman(Eds) : PTSD Brain Mechanisms and Clinical Implications, Springer, 2006 | |
| Yamasue H, Kasai K, Iwanami A, Ohtani T, Yamada H, Abe O, Kuroki N, Fukuda R, Tochigi M, Furukawa S, Sadamatsu M, Sasaki T, Aoki S, Ohtomo K, Asukai N, and Kato N. Voxel-based analysis of MRI reveals anterior cingulate gray-matter volume reduction in posttraumatic stress disorder due to terrorism. Proc Natl Acad Sci U S A 100: 9039-9043, 2003. | |
| Tomita H, Nagamitsu S, Wakui K, Fukushima Y, Yamada K, Sadamatsu M, Masui A, Konishi T, Matsuishi T, Aihara M, Shimizu K, Hashimoto K, Mineta M, Matsushima M, Tsujita T, Saito M, Tanaka H, Tsuji S, Takagi T, Nakamura Y, Nanko S, Kato N, Nakane Y, and Niikawa N. Paroxysmal kinesigenic choreoathetosis locus maps to chromosome 16p11.2-q12.1. Am J Hum Genet 65: 1688-1697, 1999. | |
| 栗田 廣 | 社会福祉法人全国心身障害児福祉財団 全国療育相談センター・センター長 |
| 児童精神医学 | |
| Reliability and validity of the Pervasive Developmental Disorders Assessment System. Kurita H, Koyama T, Inoue K. Psychiatry Clin Neurosci. 2008; 62: 226-233. | |
| External validity of childhood disintegrative disorder in comparison with autistic disorder. Kurita H, Osada H, Miyake Y. J Autism Dev Disord. 2004; 34: 355-362. | |
| School refusal in pervasive developmental disorders. Kurita H. J Autism Dev Disord 1991; 21: 1-15. | |
| 越野 好文 | 粟津神経サナトリウム特別名誉顧問 |
| 精神医学 | |
| Individual analysis of EEG band power and clinical drug response in schizophrenia. Kikuuchi M, Wada Y, Higashima M, Nagasawa T, Takeda T, Koshino Y． Neuropsychobiology 51:183-190,2005. | |
| こころのレスキュー・越野好文、志野靖史・北大路書房・2002 | |
| 好きになる精神医学・越野好文、志野靖史・講談社・2004 | |
| 小島 卓也 | 大宮厚生病院副院長 |
| 精神生理学 | |
| Eisuke Matsushima, Takuya Kojima, Shigeru Ohbayashi, Harunobu Ando, Katsumi Ando, Yasuo Shimazono:Exploratory eye movements dysfunction in patients with schizophrenia; Possibility as a discriminator for schizophrenia. Journal of Psychiatric Research 32: 289-295,1998 | |
| Kojima T, Matsushima E, Ohta K, Toru M, Han YH, Shen YC, Moussaoui D, David I, Sato K, Yamashita I, Kathmann N, Hippius H, et al., Stability of exploratory eye movements as a marker of schizophrenia-a WHO multi-center study, Schizophrenia Research, 52, 203-213, 2001 | |
1) Matsuda T, Matsuura M, Ohkubo T, Ohkubo H, Matsushima E, Inoue K, Taira M, Kojima T.：Functional MRI mapping of brain activation during visually guided saccades and antisaccades: cortical and subcortical networks.：Psychiatry Res.：131(2)：147-55：2004 |
|
| 広瀬 徹也 | 神経研究所理事長・晴和病院院長 |
| 気分障害の臨床精神病理 | |
| 躁うつ病の経過に関する臨床的研究−治療との関連において−. 広瀬徹也、精神経誌.1967;69(1):19-38. | |
| 不安と抑うつ−"不安発作−抑制型"うつ病をめぐって−. 広瀬徹也、『躁うつ病の精神病理３』（飯田 真編）、弘文堂、79-105, (1979). | |
| 「逃避型抑うつ」再考.広瀬徹也、『うつ病論の現在』（広瀬徹也、内海 健共編）、星和書店、49-68、(2005). | |
こころの健康科学研究事業中間・事後評価委員名簿 ＜神経・筋疾患分野＞
（○：委員長）
○
| 葛原 茂樹 | 国立精神・神経センター病院院長 |
| 神経変性疾患、痴呆性疾患、医原性神経疾患、脳血管障害 | |
| Kuzuhara S, Kokubo Y, Sasaki R, Narita Y, Yabana T, Hasegawa M, Iwatsubo T: Familial amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Kii peninsula of Japan: clinical and neuropathological study and tau analysis. Ann Neurol 49:501-511, 2001 | |
| Morimoto S, Kuzuhara S, Kokubo Y: Increased oxidative stress in patients with amyotrophic lateral sclerosis/parkinsonism-dementia comlex in the Kii Peninsula, Japan. Mov Disord 24:123-126, 2008 | |
| Tomiyama H, Kokubo Y, Sasaki R, Li Y, Imamichi Y, Funayama M, Mizuno Y, Hattori N, Kuzuhara S: Mutation analyses in amyotrophic lateral sclerosis/parkinsonism-dementia complex of the Kii peninsula, Japan. Mov Disord 23:2344-2348, 2008 | |
| 篠原 幸人 | 国家公務員共済組合連合会立川病院 院長 |
| 神経内科学 | |
| Shinohara Y: Hemorrhagic stroke syndrome: Clinical manifestation of intracerebral and subarachnoid hemorrhage.In "Handbook of Neurology, Vol. 93, Chap 28", ed by Mark Fisher.Elsevier, Edinburgh. pp577-594, 2009 | |
| Shinohara Y, Nishimaru K, for the S-ACCESS study group: Sarpogrelate versus aspirin in secondary prevention of cerebral infarction: Differential efficacy in diabetes? Subgroup analysis from S-ACCESS. Stroke 40:2862-2865, 2009 | |
| Shinohara Y, for the CSPS II group: Cilostazol shows superiority to aspirin for secondary stroke prevention: Results of CSPS II.International Stroke Conference 2010, 2010. | |
| 清水 夏繪 | 帝京平成大学専門学校長 |
| 神経内科学 | |
Shimizu N, Takiyama Y, Mizuno Y, Mizuno M, Saito K and Yoshida M: Characteristics of oculomotor disorders of a family with Joseph's disease. J Neurol 1990;237(7):393-398 |
|
Shimizu N, Yamami T, Nakayama M, Ikeuchi T, Koide R, Tsuji S: A sporadic case of dentatorubral pallidoluysian atrophy (DRPLA) with CAG repeat expansion but no clinical abnormalities in the father. J Neurol Neurosurg Psychiatry 1996;61(1):113-114 |
|
| 金田建志、清水夏繪：急性期脳卒中片麻痺患者における健側上肢の運動機能について、リハビリテーション医学 2002;39(2):95-98 | |
| 高守 正治 | 金沢西病院脳神経センター長 金沢大学名誉教授 |
| 神経免疫学、神経生理学 | |
| Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis. Takamori M. J Neuroimmunol. 2008 Sept; 201-202: 145-152. | |
| Autoantibodies against TRPC3 and ryanodine receptor in myasthenia gravis. Takamori M. J Neuroimmunol. 2008 Aug; 200(1-2): 142-144. | |
| Autoantibodies against M1 muscarinic acetylcholine receptor in myasthenic disorders. Takamori M, Motomura M, Fukudome T, Yoshikawa H. Eur J Neurol 2007 Nov; 14(11): 1230-1235. | |
| 田村 晃 | 富士脳障害研究所附属病院院長 |
| 脳神経外科 | |
| Thalamic atrophy following cerebral infarction in the territory of the middle cerebral artery. Tamura A, Tahira Y, Nagashima H, Kirino T, Gotoh O, Hojo S, Sano K. Stroke 1991; 22:615-618 | |
| Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Nakatomi H, Kuriu T. Okabe S, Yamamoto S, Hatano O, Kawahara N, Tamura A, Kirino T, Nakafuku M. Cell 2002; 110:429-441 | |
| 「EBMに基づく脳神経疾患の基本治療指針」田村晃、松谷雅生、清水輝夫編著、メジカルビュー社、(2006). | |
| 西澤 正豊 | 新潟大学脳研究所教授 |
| 神経内科学、分子遺伝学、神経免疫学 | |
| Hara K, Shiga A, Fukutake T, Nozaki H, Miyashita A, Yokoseki A, Kawata H, Koyama A, Arima K, Takahashi T, Ikeda M, Shiota H, Tamura M , Shimoe Y, Hirayama M, Arisato T, Yanagawa S, Tanaka A, Nakano I, Ikeda S, Yoshida Y, Yamamoto T, Ikeuchi T, Kuwano R, Nishizawa M, Tsuji S, Onodera O：Familial ischemic cerebral small-vessel disease caused by mutations in the HTRA1 gene．N Engl J Med 360 (17)：1729-1739，2009 | |
| Tada M, Kakita A, Toyoshima Y, Onodera O, Ozawa T, Morita T, Nishizawa M, Takahashi H: Depletion of medullary serotonergic neurons in patients with multiple system atrophy who succumbed to sudden death. Brain 132 (Pt 7): 1810-1819 , 2009 | |
| Yanagawa K, Kawachi I, Yokoseki A, Arakawa M, Hasegawa A, Ito Y, Kojima N, Koike R, Tanaka K, Kosaka T, Tan C-F, Toyoshima Y, Kakita A, Tsujita M, Sakimura K, Takahashi H, Nishizawa M: Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis. Neurology 73 (20)：1628-37, 2009 | |
| 御子柴 克彦 | 理化学研究所グループディレクター |
| 脳神経科学 | |
| Futatsugi, A., Nakamura, T., Yamada, M. K.,Ebisui, E., Nakamura, K., Uchida, K., Kitaguchi, T., Takahashi-Iwanaga, H., Noda, T., Aruga, J. & Mikoshiba, K.: IP3 Receptor Types 2 and 3 mediate exocrine secretion underlying energy metabolism Science 309: 2232-2234 (2005) | |
| Higo, T., Hattori, M., Nakamura, T., Natsume, T., Michikawa, T & Mikoshiba,K.:Subtype-specific and ER-lumenal-environment-dependent Regulation of Inositol 1,4,5-Trisphosphate Receptor Type 1 by ERp44. Cell 120: 85-98 (2005) | |
| Furuichi, T., Yoshikawa, S., Miyawaki, A., Wada, K., Maeda, N. & Mikoshiba, K.: Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400. Nature 342: 32-38 (1989) | |
（官職指定）
大臣官房厚生科学科長
社会・援護局障害保健福祉部企画課長
社会・援護局障害保健福祉部精神・障害保健課長
健康局疾病対策課長
医政局政策医療課長
雇用均等・児童家庭局母子保健課長
